Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 137

1.

Risk factors for fracture in adult kidney transplant recipients.

Naylor KL, Zou G, Leslie WD, Hodsman AB, Lam NN, McArthur E, Fraser LA, Knoll GA, Adachi JD, Kim SJ, Garg AX.

World J Transplant. 2016 Jun 24;6(2):370-9. doi: 10.5500/wjt.v6.i2.370.

2.

Frequency of bone mineral density testing in adult kidney transplant recipients from Ontario, Canada: a population-based cohort study.

Naylor KL, Zou G, Leslie WD, McArthur E, Lam NN, Knoll GA, Kim SJ, Fraser LA, Adachi JD, Hodsman AB, Garg AX.

Can J Kidney Health Dis. 2016 Jan 16;3:2. doi: 10.1186/s40697-016-0092-y. eCollection 2016.

3.

Trabecular bone score in kidney transplant recipients.

Naylor KL, Lix LM, Hans D, Garg AX, Rush DN, Hodsman AB, Leslie WD.

Osteoporos Int. 2016 Mar;27(3):1115-1121. doi: 10.1007/s00198-015-3424-3. Epub 2015 Nov 25.

PMID:
26608055
4.

Fracture Incidence in Adult Kidney Transplant Recipients.

Naylor KL, Jamal SA, Zou G, McArthur E, Lam NN, Leslie WD, Hodsman AB, Kim SJ, Knoll GA, Fraser LA, Adachi JD, Garg AX.

Transplantation. 2016 Jan;100(1):167-75. doi: 10.1097/TP.0000000000000808.

PMID:
26154389
5.

Estimating osteoporotic fracture risk following a wrist fracture: a tale of two systems.

Beattie K, Adachi J, Ioannidis G, Papaioannou A, Leslie WD, Grewal R, MacDermid J, Hodsman AB.

Arch Osteoporos. 2015;10:13. doi: 10.1007/s11657-015-0218-3. Epub 2015 May 9.

6.

Response to the Letter to the Editor on "Appropriate Osteoporosis Treatment by Family Physicians in Response to FRAX vs CAROC Reporting: Results From a Randomized Controlled Trial".

Beattie K, Adachi R, Papaioannou A, Hodsman A.

J Clin Densitom. 2015 Apr-Jun;18(2):270-1. doi: 10.1016/j.jocd.2015.02.002. Epub 2015 Mar 29. No abstract available.

PMID:
25833194
7.

Long-term changes in bone mineral density in kidney transplant recipients.

Naylor KL, Garg AX, Hodsman AB, Rush DN, Leslie WD.

Transplantation. 2014 Dec 27;98(12):1279-85. doi: 10.1097/TP.0000000000000284.

PMID:
25050472
8.

Build better bones with exercise: protocol for a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in women with a vertebral fracture.

Giangregorio LM, Thabane L, Adachi JD, Ashe MC, Bleakney RR, Braun EA, Cheung AM, Fraser LA, Gibbs JC, Hill KD, Hodsman AB, Kendler DL, Mittmann N, Prasad S, Scherer SC, Wark JD, Papaioannou A.

Phys Ther. 2014 Sep;94(9):1337-52. doi: 10.2522/ptj.20130625. Epub 2014 May 1.

9.

Bisphosphonates for treatment of osteoporosis: expected benefits, potential harms, and drug holidays.

Brown JP, Morin S, Leslie W, Papaioannou A, Cheung AM, Davison KS, Goltzman D, Hanley DA, Hodsman A, Josse R, Jovaisas A, Juby A, Kaiser S, Karaplis A, Kendler D, Khan A, Ngui D, Olszynski W, Ste-Marie LG, Adachi J.

Can Fam Physician. 2014 Apr;60(4):324-33. Review.

10.

FRAX predicts fracture risk in kidney transplant recipients.

Naylor KL, Leslie WD, Hodsman AB, Rush DN, Garg AX.

Transplantation. 2014 May 15;97(9):940-5. doi: 10.1097/01.TP.0000438200.84154.1a.

PMID:
24503761
11.

The three-year incidence of fracture in chronic kidney disease.

Naylor KL, McArthur E, Leslie WD, Fraser LA, Jamal SA, Cadarette SM, Pouget JG, Lok CE, Hodsman AB, Adachi JD, Garg AX.

Kidney Int. 2014 Oct;86(4):810-8. doi: 10.1038/ki.2013.547. Epub 2014 Jan 15.

12.

Appropriate osteoporosis treatment by family physicians in response to FRAX vs CAROC reporting: results from a randomized controlled trial.

Beattie KA, Ioannidis G, MacDermid JC, Grewal R, Papaioannou A, Adachi JD, Hodsman AB.

J Clin Densitom. 2014 Oct-Dec;17(4):458-65. doi: 10.1016/j.jocd.2013.09.007. Epub 2013 Oct 25.

13.

Calcium and vitamin D intake and mortality: results from the Canadian Multicentre Osteoporosis Study (CaMos).

Langsetmo L, Berger C, Kreiger N, Kovacs CS, Hanley DA, Jamal SA, Whiting SJ, Genest J, Morin SN, Hodsman A, Prior JC, Lentle B, Patel MS, Brown JP, Anastasiades T, Towheed T, Josse RG, Papaioannou A, Adachi JD, Leslie WD, Davison KS, Goltzman D; CaMos Group.

J Clin Endocrinol Metab. 2013 Jul;98(7):3010-8. doi: 10.1210/jc.2013-1516. Epub 2013 May 23.

14.

Fracture risk in kidney transplant recipients: a systematic review.

Naylor KL, Li AH, Lam NN, Hodsman AB, Jamal SA, Garg AX.

Transplantation. 2013 Jun 27;95(12):1461-70. doi: 10.1097/TP.0b013e31828eead8. Review.

PMID:
23594857
15.

Oral bisphosphonate use in the elderly is not associated with acute kidney injury.

Shih AW, Weir MA, Clemens KK, Yao Z, Gomes T, Mamdani MM, Juurlink DN, Hird A, Hodsman A, Parikh CR, Wald R, Cadarette SM, Garg AX.

Kidney Int. 2012 Oct;82(8):903-8. doi: 10.1038/ki.2012.227. Epub 2012 Jun 13.

16.

Fracture risk in living kidney donors: a matched cohort study.

Garg AX, Pouget J, Young A, Huang A, Boudville N, Hodsman A, Adachi JD, Leslie WD, Cadarette SM, Lok CE, Monroy-Cuadros M, Prasad GV, Thomas SM, Naylor K, Treleavan D; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Kidney Dis. 2012 Jun;59(6):770-6. doi: 10.1053/j.ajkd.2012.01.013. Epub 2012 Apr 1.

PMID:
22472209
17.

Bone and mineral metabolism and fibroblast growth factor 23 levels after kidney donation.

Young A, Hodsman AB, Boudville N, Geddes C, Gill J, Goltzman D, Jassal SV, Klarenbach S, Knoll G, Muirhead N, Prasad GV, Treleaven D, Garg AX; Donor Nephrectomy Outcomes Research (DONOR) Network.

Am J Kidney Dis. 2012 Jun;59(6):761-9. doi: 10.1053/j.ajkd.2011.09.019. Epub 2011 Nov 16.

PMID:
22093959
18.

Osteoporosis Canada 2010 guidelines for the assessment of fracture risk.

Lentle B, Cheung AM, Hanley DA, Leslie WD, Lyons D, Papaioannou A, Atkinson S, Brown JP, Feldman S, Hodsman AB, Jamal AS, Josse RG, Kaiser SM, Kvern B, Morin S, Siminoski K; Scientific Advisory Council of Osteoporosis Canada.

Can Assoc Radiol J. 2011 Nov;62(4):243-50. doi: 10.1016/j.carj.2011.05.001. Erratum in: Can Assoc Radiol J. 2012 May;63(2):78.

19.

The 'centre effect' in nephrology: what do differences between nephrology centres tell us about clinical performance in patient management?

Hodsman A, Ben-Shlomo Y, Roderick P, Tomson CR.

Nephron Clin Pract. 2011;119(1):c10-7; discussion c17. doi: 10.1159/000321378. Epub 2011 Jun 9. Review.

20.

Reducing the risk of re-fracture in the dialysis population: is it time to consider therapy with PTH analogues?

Jamal SA, Hodsman AB.

Semin Dial. 2011 Jan-Feb;24(1):12-5. doi: 10.1111/j.1525-139X.2010.00817.x. Epub 2011 Feb 7.

PMID:
21299630
21.

Effect of bone mineral guideline target achievement on mortality in incident dialysis patients: an analysis of the United Kingdom Renal Registry.

Tangri N, Wagner M, Griffith JL, Miskulin DC, Hodsman A, Ansell D, Naimark DM.

Am J Kidney Dis. 2011 Mar;57(3):415-21. doi: 10.1053/j.ajkd.2010.08.037. Epub 2010 Dec 4.

PMID:
21131115
22.

2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary.

Papaioannou A, Morin S, Cheung AM, Atkinson S, Brown JP, Feldman S, Hanley DA, Hodsman A, Jamal SA, Kaiser SM, Kvern B, Siminoski K, Leslie WD; Scientific Advisory Council of Osteoporosis Canada.

CMAJ. 2010 Nov 23;182(17):1864-73. doi: 10.1503/cmaj.100771. Epub 2010 Oct 12. No abstract available.

23.

Canadian Society of Transplantation and Canadian Society of Nephrology commentary on the 2009 KDIGO clinical practice guideline for the care of kidney transplant recipients.

Knoll GA, Blydt-Hansen TD, Campbell P, Cantarovich M, Cole E, Fairhead T, Gill JS, Gourishankar S, Hebert D, Hodsman A, House AA, Humar A, Karpinski M, Kim SJ, Mainra R, Prasad GV.

Am J Kidney Dis. 2010 Aug;56(2):219-46. doi: 10.1053/j.ajkd.2010.05.004. No abstract available.

PMID:
20659623
24.

Canadian Society of Nephrology commentary on the 2009 KDIGO Clinical Practice Guideline for the Diagnosis, Evaluation, and Treatment of CKD-Mineral and Bone Disorder (CKD-MBD).

Manns BJ, Hodsman A, Zimmerman DL, Mendelssohn DC, Soroka SD, Chan C, Jindal K, Klarenbach S.

Am J Kidney Dis. 2010 May;55(5):800-12. doi: 10.1053/j.ajkd.2010.02.339. No abstract available.

PMID:
20438984
25.

Development and utility of a multi-dimensional grid to assess individual mineral metabolism control in hemodialysis patients: A potential aid for therapeutic decision making?

Morton AR, Murphy S, Hirsch D, Leblanc M, Barré P, Lok C, Hercz G, Hodsman A, Reslerova M, Levin A.

Hemodial Int. 2010 Apr;14(2):200-10. doi: 10.1111/j.1542-4758.2009.00426.x. Epub 2010 Mar 12.

PMID:
20337745
26.

Functional analysis of a type 1 parathyroid hormone receptor intracellular tail mutant [KRK(484-6)AAA]: effects on second messenger generation and cellular targeting.

Patterson EK, Hodsman AB, Hendy GN, Canaff L, Bringhurst FR, Fraher LJ.

Bone. 2010 Apr;46(4):1180-7. doi: 10.1016/j.bone.2009.12.005. Epub 2009 Dec 16.

PMID:
20006743
27.

The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC).

Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Walsh A, Jiwa F, Adachi JD.

BMC Med Educ. 2009 Aug 6;9:54. doi: 10.1186/1472-6920-9-54.

28.

UK Renal Registry 11th Annual Report (December 2008): Chapter 4 ESRD prevalent rates in 2007 in the UK: national and centre-specific analyses.

Farrington K, Hodsman A, Casula A, Ansell D, Feehally J.

Nephron Clin Pract. 2009;111 Suppl 1:c43-68. doi: 10.1159/000209993. Epub 2009 Mar 26.

29.

UK Renal Registry 11th Annual Report (December 2008): Chapter 10 Biochemistry profile of patients receiving dialysis in the UK in 2007: national and centre-specific analyses.

Hodsman A, Lamb EJ, Steenkamp R, Warwick G.

Nephron Clin Pract. 2009;111 Suppl 1:c185-225. doi: 10.1159/000209999. Epub 2009 Mar 26.

30.

UK Renal Registry 11th Annual Report (December 2008): Chapter 7 Survival and causes of death of UK adult patients on renal replacement therapy in 2007: national and centre-specific analyses.

Ansell D, Roderick P, Hodsman A, Ford D, Steenkamp R, Tomson C.

Nephron Clin Pract. 2009;111 Suppl 1:c113-39. doi: 10.1159/000209996. Epub 2009 Mar 26.

31.

Family physicians' personal and practice characteristics that are associated with improved utilization of bone mineral density testing and osteoporosis medication prescribing.

Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Walsh A, Jiwa F, Adachi JD.

Popul Health Manag. 2009 Jun;12(3):131-8. doi: 10.1089/pop.2008.0025.

32.

Use of FTIR spectroscopic imaging to identify parameters associated with fragility fracture.

Gourion-Arsiquaud S, Faibish D, Myers E, Spevak L, Compston J, Hodsman A, Shane E, Recker RR, Boskey ER, Boskey AL.

J Bone Miner Res. 2009 Sep;24(9):1565-71. doi: 10.1359/jbmr.090414.

33.

10-year probability of recurrent fractures following wrist and other osteoporotic fractures in a large clinical cohort: an analysis from the Manitoba Bone Density Program.

Hodsman AB, Leslie WD, Tsang JF, Gamble GD.

Arch Intern Med. 2008 Nov 10;168(20):2261-7. doi: 10.1001/archinte.168.20.2261.

PMID:
19001204
34.

Optimizing care in osteoporosis: the Canadian quality circle project.

Ioannidis G, Thabane L, Gafni A, Hodsman A, Kvern B, Johnstone D, Plumley N, Salach L, Jiwa F, Adachi JD, Papaioannou A.

BMC Musculoskelet Disord. 2008 Oct 1;9:130. doi: 10.1186/1471-2474-9-130.

35.

Risk factors for low bone mass in healthy 40-60 year old women: a systematic review of the literature.

Waugh EJ, Lam MA, Hawker GA, McGowan J, Papaioannou A, Cheung AM, Hodsman AB, Leslie WD, Siminoski K, Jamal SA; Perimenopause BMD Guidelines Subcommittee of Osteoporosis Canada.

Osteoporos Int. 2009 Jan;20(1):1-21. doi: 10.1007/s00198-008-0643-x. Epub 2008 Jun 4. Review.

36.

Management of anaemia in haemodialysis and peritoneal dialysis patients (chapter 8).

Richardson D, Hodsman A, van Schalkwyk D, Tomson C, Warwick G.

Nephrol Dial Transplant. 2007 Aug;22 Suppl 7:vii78-104.

PMID:
17724054
37.

The Renal Long Term Care Workforce Survey (in conjunction with the British Renal Society) (chapter 16).

Macdonald J, Mahon A, O'Donoghue D, Stevens P, Hodsman A, Tomson C.

Nephrol Dial Transplant. 2007 Aug;22 Suppl 7:vii184. No abstract available.

PMID:
17724047
38.

Factors which may influence cardiovascular disease in dialysis and transplant patients--blood pressure (chapter 10).

Harper J, Hodsman A, Gilg J, Ansell D, Williams AJ.

Nephrol Dial Transplant. 2007 Aug;22 Suppl 7:vii119-37.

PMID:
17724041
39.

Serum calcium, phosphate, parathyroid hormone, albumin, aluminium and cholesterol achievement on replacement therapy (chapter 9).

Lamb EJ, Hodsman A, van Schalkwyk D, Ansell D, Warwick G.

Nephrol Dial Transplant. 2007 Aug;22 Suppl 7:vii105-18.

PMID:
17724039
40.

Canadian Quality Circle pilot project in osteoporosis: rationale, methods, and feasibility.

Ioannidis G, Papaioannou A, Thabane L, Gafni A, Hodsman A, Kvern B, Johnstone D, Plumley N, Baldwin A, Doupe M, Katz A, Salach L, Adachi JD.

Can Fam Physician. 2007 Oct;53(10):1694-700. Erratum in: Can Fam Physician. 2007 Dec;53(12):2105.

41.

Re-exposure to mismatched HLA class I is a significant risk factor for graft loss: multivariable analysis of 259 kidney retransplants.

House AA, Chang PC, Luke PP, Leckie SH, Howson WT, Ball EJ, Tan AK, Rehman F, Muirhead N, Hollomby DJ, McAlister VC, Hodsman AB, Jevnikar AM.

Transplantation. 2007 Sep 27;84(6):722-8.

PMID:
17893605
42.

Long-term dalteparin in pregnancy not associated with a decrease in bone mineral density: substudy of a randomized controlled trial.

Rodger MA, Kahn SR, Cranney A, Hodsman A, Kovacs MJ, Clement AM, Lazo-Langner A, Hague WM; TIPPS investigators.

J Thromb Haemost. 2007 Aug;5(8):1600-6.

43.

Expression of PTH1R constructs in LLC-PK1 cells: protein nuclear targeting is mediated by the PTH1R NLS.

Patterson EK, Watson PH, Hodsman AB, Hendy GN, Canaff L, Bringhurst FR, Poschwatta CH, Fraher LJ.

Bone. 2007 Oct;41(4):603-10. Epub 2007 Jun 2.

PMID:
17627912
44.

Recommendations for bone mineral density reporting in Canada: a shift to absolute fracture risk assessment.

Siminoski K, Leslie WD, Frame H, Hodsman A, Josse RG, Khan A, Lentle BC, Levesque J, Lyons DJ, Tarulli G, Brown JP.

J Clin Densitom. 2007 Apr-Jun;10(2):120-3. Epub 2007 Feb 16. Review.

PMID:
17485028
45.

Recognizing and reporting vertebral fractures: reducing the risk of future osteoporotic fractures.

Lentle BC, Brown JP, Khan A, Leslie WD, Levesque J, Lyons DJ, Siminoski K, Tarulli G, Josse RG, Hodsman A; Scientific Advisory Council of Osteoporosis Canada; Canadian Association of Radiologists.

Can Assoc Radiol J. 2007 Feb;58(1):27-36.

PMID:
17408160
46.
47.

Management of osteoporosis in men: an update and case example.

Khan AA, Hodsman AB, Papaioannou A, Kendler D, Brown JP, Olszynski WP.

CMAJ. 2007 Jan 30;176(3):345-8. Review.

48.

Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium.

Lindsay R, Zhou H, Cosman F, Nieves J, Dempster DW, Hodsman AB.

J Bone Miner Res. 2007 Apr;22(4):495-502.

49.

Bone strength: the whole is greater than the sum of its parts.

Davison KS, Siminoski K, Adachi JD, Hanley DA, Goltzman D, Hodsman AB, Josse R, Kaiser S, Olszynski WP, Papaioannou A, Ste-Marie LG, Kendler DL, Tenenhouse A, Brown JP.

Semin Arthritis Rheum. 2006 Aug;36(1):22-31. Epub 2006 Jul 3. Review.

PMID:
16887465
50.

The effects of antifracture therapies on the components of bone strength: assessment of fracture risk today and in the future.

Davison KS, Siminoski K, Adachi JD, Hanley DA, Goltzman D, Hodsman AB, Josse R, Kaiser S, Olszynski WP, Papaioannou A, Ste-Marie LG, Kendler DL, Tenenhouse A, Brown JP.

Semin Arthritis Rheum. 2006 Aug;36(1):10-21. Epub 2006 Jul 3. Review.

PMID:
16887464

Supplemental Content

Loading ...
Support Center